SEC Company Response from PALISADE BIO, INC. (PALI) (CIK 0001357459) (PALI) — Apr 1, 2009
PALISADE BIO, INC. (PALI) (CIK 0001357459)
Date: April 1, 2009 · CIK: 0001357459 · Accession: 0001144204-09-018394
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-157079
Letter
Division of Corporation Finance United States Securities and Exchange Commission RE: Neuralstem, Inc. (“Issuer”) Registration Statement on Form S-3 File No. 333-157079
Dear Mr. Riedler:
Based upon a telephone conversation with your staff, Neuralstem, Inc. is hereby requesting the above referenced registration statement be declared effective at 1:00 p.m. EST, on Friday, April 3, 2009 or as soon as practicable thereafter.
We hereby acknowledge that:
1.
should the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, such action will not foreclose the Commission from taking any action with respect to the filing;
2.
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, will not relieve the Issuer from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
3.
The Issuer may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very
truly yours,
/s/ John
Conron
Show Raw Text
CORRESP
1
filename1.htm
NEURALSTEM,
INC.
April 1, 2009
Jeffrey P. Riedler
Assistant Director
Division of Corporation
Finance
Mail Stop 6010
United States Securities and Exchange
Commission
Washington, DC 20549
RE:
Neuralstem, Inc. (“Issuer”)
Registration Statement on Form
S-3
File No. 333-157079
Dear Mr. Riedler:
Based upon a telephone conversation with your staff, Neuralstem, Inc. is hereby requesting
the above referenced registration statement be declared
effective at 1:00 p.m. EST, on Friday, April 3, 2009 or as soon as practicable
thereafter.
We hereby acknowledge
that:
1.
should the Commission or the
staff, acting pursuant to delegated authority, in declaring the filing
effective, such action will not foreclose the Commission from taking any
action with respect to the
filing;
2.
the action of the Commission or
the staff, acting pursuant to delegated authority, in declaring the filing
effective, will not relieve the Issuer from its full responsibility for
the adequacy and accuracy of the disclosure in the filing;
and
3.
The Issuer may not assert staff comments and
the declaration of effectiveness as a defense in any proceeding initiated
by the Commission or any person under the federal securities laws of the
United States.
Very
truly yours,
/s/ John
Conron
John
Conron
Chief
Financial Officer